Rheumatoid arthritis C. treatment and assessments

Alyce M. Oliver, E. William St. Clair

Research output: Chapter in Book/Report/Conference proceedingChapter

9 Scopus citations


The assessment of RA demands a careful history and examination, with a detailed joint count to determine disease activity. The level of clinical disease activity largely determines the need for therapy. DMARDs are central to the control of disease activity and resulting joint damage. The availability of an expanding array of DMARDs and biologics has created new opportunities to effectively intervene in this condition. The standard of care for RA continues to evolve with increasing evidence that persistent joint inflammation leads to irreversible damage and disability. As a result, combination DMARD regimens are being employed to afford optimal disease control in order to avert permanent joint injury.

Original languageEnglish (US)
Title of host publicationPrimer on the Rheumatic Diseases
Subtitle of host publicationThirteenth Edition
PublisherSpringer New York
Number of pages9
ISBN (Print)9780387356648
StatePublished - Dec 1 2008
Externally publishedYes

ASJC Scopus subject areas

  • Medicine(all)


Dive into the research topics of 'Rheumatoid arthritis C. treatment and assessments'. Together they form a unique fingerprint.

Cite this